Procurement Summary
Country : USA
Summary : Budesonide Inhalation Suspension
Deadline : 25 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 99956823
Document Ref. No. : Solicitation_SPE2D224R0005
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : DEPT OF DEFENSE
Contracting Office Address : PHILADELPHIA, PA 19111
Primary Point of Contact : Nancy Fernandez
nancy.fernandez@dla.mil
Phone Number 215-737-4955
Secondary Point of Contact : Catherine Gilbert
catherine.gilbert@dla.mil
Phone Number 2157374778
USA
Email :nancy.fernandez@dla.mil
Tender Details
Description
See attachment.
Active Contract Opportunity Notice ID Solicitation_SPE2D224R0005 Related Notice SPE2D2-24-R-0005 Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Apr 10, 2024 03:33 pm EDT
Original Published Date: Mar 12, 2024 09:05 am EDT
Updated Date Offers Due: Apr 25, 2024 03:00 pm EDT
Original Date Offers Due: Apr 11, 2024 03:00 pm EDT
Inactive Policy: Manual
Updated Inactive Date: Apr 25, 2029
Original Inactive Date: Apr 12, 2029
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:
Documents
Tender Notice
SPE2D224R00050002_Amendment-0002-for-Budesonide.pdf
Updated-Schedule-of-Supplies.pdf
SPE2D224R00050001.PDF
Solicitation_Budesonide-National-Contract_SPE2D224R0005_updated-12.March.2024.pdf